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400mg/ritonavir 100mg (Kaletra two tablets, 
twice a day)  
or chloroquine 500mg orally per day. 
Or Hydroxychloroquine 400mg/day 
Kwak S-s. Physicians work out treatment guidelines for coronavirus Febr. 13 , 












Chloroquine, 500 mg each time, twice a day 
for 10 days.  
In case of severe gastrointestinal reactions, 
the dose can be reduced to 1 time / day, 500 
mg each time (Google trad. Translated from 
Chinese by Google trad) 
Mingxing H, Tiantian T, Multicenter collaboration group of the Department 
of Science and Technology of Guangdong Province, Health Commission of 
Guangdong Province for chloroquine in the treatment of novel coronavirus. 
磷酸氯喹治疗新型冠状病毒肺炎的专家共识 [Expert consensus on 
chloroquine phosphate for the treatment of novel coronavirus pneumonia]. 
Zhonghua Jie He He Hu Xi Za Zhi (Chinese Journal of Tuberculosis and 
Respiratory Disease). 2020;43(0):E019 Available from: 







Chloroquine phosphate can be used on adults 
between 18-65 years old   
(weight ≥ 50 kg: 500 mg bid; weight < 50kg: 
500 mg bid for first two days, 500 mg qd for 
following five days). 
Handbook of COVID-19 prevention and treatment. Liang T, editor: Zhejiang 












HCQ 400 mg per day for 5 days  
 
Chen, Jun, et al. "A pilot study of hydroxychloroquine in treatment of 
patients with common coronavirus disease-19 (COVID-19)." Journal of 










400 mg twice daily of hydroxychloroquine 
sulfate given orally, followed by a 
maintenance dose of 200 mg given twice daily 
for 4 days is recommended for SARS-CoV-2 
infection,  
Hydroxychloroquine was found to be more 
potent than chloroquine. 
Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In Vitro Antiviral Activity 
and Projection of Optimized Dosing Design of Hydroxychloroquine for the 
Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-





GHDC.be   
Hydroxychloroquine 
800mg day 1 400mg day 2 to 5 
With Azithromycine 
Personal communication,  






Diseases & all. 
Hydroxychloroquine: 800 mg day 1, 400mg 
day 2 to 10 
Or Chloroquine 1000 mg day 1, 500M day 2 to 
10 
Azithromycin 500 mg   5 days   
SIMIT, FIMMG, SIMG. Home management of early therapy Covid-19 March 








University et all. 
Oral hydroxychloroquine sulfate 200 mg, three 
times per day during ten days  
Azithromycin added to hydroxychloroquine 
was significantly more efficient for virus 
elimination 
Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. 
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of 
an open label non-randomized clinical trial. Ahead of print. March, 2020 
 





Hospital of Sun 
Yat-sen Univ, 
Guangzhou 
≥50kg 500mg every time, twice daily 7 days  
<50kg for the 1st and 2nd days, 500mg every 
time,twice daily; from the 3rd to the 7th days, 
500mg every time, once daily 
Personal communication 
Dr Shanping Jiang,  





Hydroxychloroquine 200mg twice a day for 5 
days 
Azithromycin 500mg once a day for 5 days 
Zinc sulfate 220mg once a day for 5 days 
Letter from Dr. Vladimir (Zev) Zelenko, Board Certified Family Practitioner 










Hospital  of  
Wuhan  Univ, et 
all 
 400  mg/d  (200  mg/bid)  
between  days 1 and 5 
Chen et all. Efficacy  of  hydroxychloroquine  in  patients  with  COVID-19:  





Saúde do Brazil 
Chloroquine   
90O mg day 1 / 450 mg day 2 to 5 
Hydroxychloroquine  
800mg day 1  /  400mg day 2 to 5 
Ministério da Saúde Secretaria de Ciência. Brasil Nota informativa Nº 6/2020-








Chloroquine phosphate:  
 COVID-19 URTI: 1000 mg  for 5 days.  
 COVID-19 LRTI: 1000 mg for 10 days.  
Hydroxychloroquine:  
800 mg day 1, 400mg day 2 to 5 
Singh, A. K. & all (2020). Chloroquine and hydroxychloroquine in the 
treatment of COVID-19 with or without diabetes: A systematic search and a 
narrative review with a special reference to India and other developing 








Molina JM,et al. No evidence of rapid antiviral clearance or clinical benefit 
with the combination of hydroxychloroquine and azithromycin in patients 









URTI & PCR+: • Chloroquine phosphate 500 
mg BID for 5 days. • Oseltamivir 150 mg BID 
for 5 days.  
COVID-19 Pneumonia: • Chloroquine 
phosphate 500 mg BID for 5 days plus 
Darunavir 800 mg/Cobicistat 150 mg OD for 2 
weeks. • Atazanavir 400 mg OD for 2 weeks 
plus Oseltamivir 150 mg BID for 5 days. 
CDC MICC TEAM. Treatment of confirmed COVID-19 case Atlanta: CDC; Aprl 









600 mg of Chloroquine followed by 300 mg 
after 12 h on day 1, then 300 mg × 2/day per 
person on days 2–5.  
Or 800 mg hydroxychloroquine on day 1, then 
400 mg hydroxychloroquine on day 2-5  









AFMPS - FAGC. 
Mild/Moderate/Severe COVID-19: 
Hydroxychloroquine 800mg day 1 , 400mg day 
2 - 5,  
Or, Chloroquine 600 mg at diagnosis and 300 
mg 12 hour later followed by 600 mg day 1 - 5  
Critical COVID-19: Remdesivir 200 mg loading 
dose i.v within 30 minutes followed by 100 mg 
OD for 2-10 days (Hydroxychloroquine is 
second option if Remdesivir is unavailable) 
IMT, Univ Antwerpen, Sciensano, CHU ST PIerre, AFMPS - FAGC. Interim 
clinical guidance for adults with suspected or confirmed Covid-19 in Belgium 










800 mg once daily on day 1, followed by 200 
mg twice daily for 7 days 
Perinel S, Launay M, Botelho-Nevers E, Diconne E, Louf-Durier A, Lachand R, 
et al. Towards Optimization of Hydroxychloroquine Dosing in Intensive Care 














Patients with severe diseases; HCQ: 400 mg 
BD for one day followed by 200 mg BD for 4 
days, in combination with Azithromycin: 500 
mg OD for 5 days. 
Symptomatic healthcare workers involved in 
the care of suspected or confirmed cases of 
COVID-19: 400 mg twice a day on Day 1, 
followed by 400 mg once weekly for next 7 
weeks, to be taken with meals 
Asymptomatic household contacts of 
laboratory confirmed cases: 400 mg twice a 
day on Day 1, followed by 400 mg once weekly 
for next 3 weeks; to be taken with meals. 
Kapoor, A., Pandurangi, U., Arora, V., Gupta, A., Jaswal, A., Nabar, A., ... & 
Yadav, R. (2020). Cardiovascular risks of hydroxychloroquine in treatment 
and prophylaxis of COVID-19 patients: A scientific statement from the Indian 








University et all. 
200 mg of oral hydroxychloroquine sulfate, 
three times per day for ten days combined 
with azithromycin (500mg on D1 followed by 
250mg per day for the next four days). 
Gautret P, Lagier JC, Parola P, et al. Clinical and microbiological effect of a 
combination of hydroxychloroquine and azithromycin in 80 COVID-19 
patients with at least a six-day follow up: A pilot observational study 
[published online ahead of print, 2020 Apr 11]. Travel Med Infect Dis. 










Chloroquine 500mg BID 7 to 10 days 
Hydroxychloroquine 200mg each 8 hours 7 to 
10 days 
Prophylaxis : 
Exposed health workers ; 400mg day 1 
followed by 400mg each week, 7 weeks 
Contact of confirmed cases : 400mg day 1 
followed by 400mg each week, 3 weeks 
Resolución Ministerial N° 193-2020-MINSA. Prevención, Diagnóstico y 








Hydroxychloroquine 800mg on the first day 
and 400mg for another 6 days and 
azithromycin 500mg once daily for five days. 
 
Rodrigo Esper et all Empirical treatment with hydroxychloroquine and 
azithromycin for suspected cases of COVID-19 followed-up by telemedicine . 
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